Amifostine in the management of radiation-induced and chemo-induced mucositis

被引：48

作者：

Bensadoun, Rene-Jean

Schubert, Mark M.

Lalla, Rajesh V.

Keefe, Dorothy

机构：

[1] Ctr Antoine Lacassagne, Dept Radiat Oncol, F-06189 Nice 2, France

[2] Univ Washington, Dept Oral Med, Oral Med Serv, Seattle Canc Care Alliance, Seattle, WA 98109 USA

[3] Univ Connecticut, Ctr Hlth, Dept Oral Hlth & Diagnost Sci MC1605, Farmington, CT 06030 USA

[4] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia

来源：

SUPPORTIVE CARE IN CANCER | 2006年 / 14卷 / 06期

关键词：

amifostine; mucositis; radiotheraphy; chemotheraphy;

D O I：

10.1007/s00520-006-0047-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Introduction: Mucositis is a significant complication of cancer therapy, with important clinical and economic implications. In June 2005, the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO) conducted an evidence-based update review of the literature on mucositis. The goal of this literature review is to update previously published guidelines for the management of mucositis. Results: This article reports the findings of the subgroup charged with reviewing the literature related to amifostine.

引用

收藏

页码：566 / 572

页数：7

相关论文

共 43 条

[1] Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer [J].

Antonadou, D ;

Throuvalas, N ;

Petridis, A ;

Bolanos, N ;

Sagriotis, A ;

Synodinou, M .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (02) :402-408

[2] Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer [J].

Antonadou, D .

SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :50-58

[3] Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer [J].

Antonadou, D ;

Pepelassi, M ;

Synodinou, M ;

Puglisi, M ;

Throuvalas, N .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03) :739-747

[4] Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation [J].

Arquette, M ;

Wasserman, T ;

Govindan, R ;

Garfield, D ;

Senzer, N ;

Gillenwater, H ;

Socinski, M .

SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :59-61

[5] Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of a randomized trial [J].

Athanassiou, H ;

Antonadou, D ;

Coliarakis, N ;

Kouveli, A ;

Synodinou, M ;

Paraskevaidis, M ;

Sarris, G ;

Georgakopoulos, GR ;

Panousaki, K ;

Karageorgis, P ;

Throuvalas, N .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (04) :1154-1160

[6] Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy [J].

Bardet, E ;

Martin, L ;

Calais, G ;

Tuchais, C ;

Bourhis, J ;

Rhein, B ;

Feham, N ;

Alphonsi, M .

SEMINARS IN ONCOLOGY, 2002, 29 (06) :57-60

[7] Intrarectal application of amifostine for the prevention of radiation-induced rectal injury [J].

Ben-Josef, E ;

Han, S ;

Tobi, M ;

Vargas, BJ ;

Stamos, B ;

Kelly, L ;

Biggar, S ;

Kaplan, I .

SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :81-85

[8] A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury [J].

Ben-Josef, E ;

Han, S ;

Tobi, M ;

Shaw, LM ;

Bonner, HS ;

Vargas, BJ ;

Prokop, S ;

Stamos, B ;

Kelly, L ;

Biggar, S ;

Kaplan, I .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (05) :1160-1164

[9] Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study [J].

Benesch, M ;

McDonald, GB ;

Schubert, M ;

Appelbaum, FR ;

Deeg, HJ .

BONE MARROW TRANSPLANTATION, 2003, 32 (11) :1071-1075

[10] New dosing regimens for amifostine: A pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion [J].

Bonner, HS ;

Shaw, LM .

JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (02) :166-174

← 1 2 3 4 5 →